C. Saltini (Rome, Italy), A. Sanduzzi (Naples, Italy)
Impact of genotype on the course of pulmonary tuberculosis in new cases patients of Armenian population
M. D. Safaryan, L. T. Nikolayan, D. G. Khachatryan (Yerevan, Armenia)
|  |
DNA-microarray genotyping using oligonucleotide linker of carbodiimides for N-acetyltransferase2 polymorphism on anti-tuberculosis drug-induced hepatotoxicity
K. Dobashi, Y. Shimizu, A. Ono, M. Utsugi, T. Kawada, T. Hisada, T. Ishizuka, M. Mori (Maebashi, Japan)
| |
Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis
M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, P. Tabarsi, F. Mohammadi, M. R. Masjedi, A. A. Velayati (Tehran, Tabriz, Islamic Republic Of Iran)
| |
Geologic heterogeneity of urban territory and pulmonary tuberculosis sick rate
N. V. Kuzmina, V. A. Karpin (Surgut, Russian Federation)
| |
The use of food packages as incentive to increase adherence to TB treatment in homeless patients in St. Petersburg, Russia
I. Stavchanskaja, B. Garden, R. Alsterlund, A. Moller, A. Samarina, L. Shpakovskaja, M. Zachinskaya, V. Zhemkov, L. O. Larsson (St. Petersburg, Russian Federation; Stockholm, Sweden)
| |
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
S. Haghighi, H. Akbarshahi, S. Mahdavi, H. Emami, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
In vitro immunodiagnosis of MTB infection in TB+ and TB+/HIV-1+ Bulgarian patients
R. K. Markova, R. H. Drenska, V. I. Terzieva, Y. D. Todorova, D. I. Stefanova, I. I. Elenkov, M. I. Yankova (Sofia, Bulgaria)
| |
High expression apoptotic proteins; P53, FAS, and BAX associated with down regulation of BCL-2 in tuberculosis granulomas: an immunohistochemistry study
S. Karimi, F. Mohammadi, P. Tabarsi, A. Mirafsharieh, Z. Mohammadtaheri, M. Bahadori (Tehran, Islamic Republic Of Iran)
| |
Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy
M. V. Amiri, D. Mansouri, M. Shekarabi, M. Mirsaidi, K. Kiahashemi, M. Masjedi (Tehran, Islamic Republic Of Iran)
| |
The evaluation of clarithromycin (CAM) in bronchial epithelial lining fluid (ELF) using bronchoscopic microsampling (BMS) probes is useful in the management of patients with pulmonary Mycobacterium avium complex (MAC)
T. Nishimura, N. Hasegawa, M. Watanabe, A. Ishizaka (Shinanomachi, Shinjuku, Japan)
| |
Treatment‘s side effects in MDR tuberculosis patients
I. G. Stoica (Bucharest, Romania)
| |
Outcome of treatment of TB/HIV patients in a referral center in Iran National Research Institute of Tuberculosis and Lung Disease
P. Tabarsi, S. M. Mirsaeidi, M. Amiri, S. D. Mansouri, P. Farnia, M. R. Masjedi, A. A. Velayati (Tehran, Islamic Republic Of Iran)
| |
Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis
M. R. Bloorsaz, S. Khalilzadeh (Tehran, Islamic Republic Of Iran)
| |
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients
M. Mirsaedi, S. Mohammadian, A. Ostad Rahimi, J. Baghdadchi, S. D. Mansouri, S. Shaghasempour, A. A. Velayati (Tehran, Islamic Republic Of Iran)
| |
Strengthening the DOTS-Plus TB Control Programme in Estonia 2002-2004 (a pilot project for intensified case finding in high-risk groups in the Ida-Virumaa region)
V. Iljina, V. Hollo, K. Vink, M. Danilovits, K. Kliiman (Kohtla-Jarve, Tallinn, Tartu, Estonia)
| |
Vestibular toxicity, an unusual side effect of isoniazid
S. Azzabi, H. Aouina, L. Gharbi, R. B. Mefteh, M. Azzouz, M. A. Baccar, H. Bouacha (Tunis, Tunisia)
| |
Risk factors for the default from DOTS - experience of the Iasi County, Romania
A. Sorete-Arbore, V. Cojocariu, T. Mihaescu (Iasi, Romania)
| |
Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT)
T. A. Alexandrina, S. A. Cherenko, M. S. Cherenko (Kiev, Riev, Ukraine)
| |
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis
F. Sahin, F. Atabey, H. Can, S. Öztürk, A. Poluman (Istanbul, Turkey)
| |